Genetic heterologous prime-boost vaccination strategies for improved systemic and mucosal immunity

被引：37

作者：

Ranasinghe, Charani ^{[1
]}

Ramshaw, Ian A. ^{[1
]}

机构：

[1] Australian Natl Univ, John Curtin Sch Med Res, Emerging Pathogens & vaccines Program, Canberra, ACT 2601, Australia

来源：

EXPERT REVIEW OF VACCINES | 2009年 / 8卷 / 09期

基金：

英国医学研究理事会;

关键词：

cell-mediated immunity; costimulatory molecule; DNA vaccine; HIV; mucosal vaccine; prime-boost; T-cell avidity; CD8(+) T-CELLS; RECOMBINANT FOWLPOX VIRUS; DRAINING LYMPH-NODES; PHASE-I TRIAL; VACCINIA VIRUS; DNA VACCINES; ANTIBODY-RESPONSES; NONHUMAN-PRIMATES; VIRAL REPLICATION; RHESUS MACAQUES;

D O I：

10.1586/ERV.09.86

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

In this article, we discuss the advantages and progress made with heterologous prime-boost vaccination strategies. Although the consecutive use of DNA and recombinant viral vectors induce greatly enhanced and sustained levels of both cell-mediated and humoral immunity in preclinical models, the results have not yet been translated to clinical use. Despite this, there is still a high level of optimism that these strategies offer the best hope for the development of vaccines against diseases for which there are no effective vaccines currently available. In this article, we discuss how prime-boost immunization can elicit improved mucosal immunity, how 'mucosal' regimes also elicit 'high-quality' (high-avidity) T-cell responses to vaccine antigens, and the use of cytokines/chemokines as genetic adjuvants.

引用

收藏

页码：1171 / 1181

页数：11

相关论文

共 117 条

[1] A push-pull approach to maximize vaccine efficacy: Abrogating suppression with an IL-13 inhibitor while augmenting help with granulocyte/macrophage colony-stimulating factor and CD40L [J].

Ahlers, JD ;

Belyakov, IM ;

Terabe, M ;

Koka, R ;

Donaldson, DD ;

Thomas, EK ;

Berzofsky, JA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13020-13025

[2] Differential expansion and survival of high and low avidity cytotoxic T cell populations during the immune response to a viral infection [J].

Alexander-Miller, MA .

CELLULAR IMMUNOLOGY, 2000, 201 (01) :58-62

[3] High-avidity CD8+ T cells -: Optimal soldiers in the war against viruses and tumors [J].

Alexander-Miller, MA .

IMMUNOLOGIC RESEARCH, 2005, 31 (01) :13-24

[4] Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL [J].

AlexanderMiller, MA ;

Leggatt, GR ;

Sarin, A ;

Berzofsky, JA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :485-492

[5] Induction of AIDS virus-specific CTL activity in fresh, unstimulated peripheral blood lymphocytes from rhesus macaques vaccinated with a DNA prime/modified vaccinia virus Ankara boost regimen [J].

Allen, TM ;

Vogel, TU ;

Fuller, DH ;

Mothé, BR ;

Steffen, S ;

Boyson, JE ;

Shipley, T ;

Fuller, J ;

Hanke, T ;

Sette, A ;

Altman, JD ;

Moss, B ;

McMichael, AJ ;

Watkins, DI .

JOURNAL OF IMMUNOLOGY, 2000, 164 (09) :4968-4978

[6] Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine [J].

Amara, RR ;

Villinger, F ;

Altman, JD ;

Lydy, SL ;

O'Neil, SP ;

Staprans, SI ;

Montefiori, DC ;

Xu, Y ;

Herndon, JG ;

Wyatt, LS ;

Candido, MA ;

Kozyr, NL ;

Earl, PL ;

Smith, JM ;

Ma, HL ;

Grimm, BD ;

Hulsey, ML ;

Miller, J ;

McClure, HM ;

McNicholl, JM ;

Moss, B ;

Robinson, HL .

SCIENCE, 2001, 292 (5514) :69-74

[7] Elicitation of simian immunodeficiency virus-specific cytotoxic T lymphocytes in mucosal compartments of rhesus monkeys by systemic vaccination [J].

Baig, J ;

Levy, DB ;

McKay, PF ;

Schmitz, JE ;

Santra, S ;

Subbramanian, RA ;

Kuroda, MJ ;

Lifton, MA ;

Gorgone, DA ;

Wyatt, LS ;

Moss, B ;

Huang, Y ;

Chakrabarti, BK ;

Xu, L ;

Kong, WP ;

Yang, ZY ;

Mascola, JR ;

Nabel, GJ ;

Carville, A ;

Lackner, AA ;

Veazey, RS ;

Letvin, NL .

JOURNAL OF VIROLOGY, 2002, 76 (22) :11484-11490

[8] Vaccination with HIV 1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunit [J].

Barnett, SW ;

Rajasekar, S ;

Legg, H ;

Doe, B ;

Fuller, DH ;

Haynes, JR ;

Walker, CM ;

Steimer, KS .

VACCINE, 1997, 15 (08) :869-873

[9] Plasmid chemokines and colony-stimulating factors enhance the immunogenicity of DNA priming-viral vector boosting human immunodeficiency virus type 1 vaccines [J].

Barouch, DH ;

McKay, PF ;

Sumida, SM ;

Santra, S ;

Jackson, SS ;

Gorgone, DA ;

Lifton, MA ;

Chakrabarti, BK ;

Xu, L ;

Nabel, GJ ;

Letvin, NL .

JOURNAL OF VIROLOGY, 2003, 77 (16) :8729-8735

[10] Generation of functionally active HIV-1 specific CD8+ CTL in intestinal mucosa following mucosal, systemic or mixed prime-boost immunization [J].

Belyakov, Igor M. ;

Ahlers, Jeffrey D. ;

Nabel, Gary J. ;

Moss, Bernard ;

Berzofsky, Jay A. .

VIROLOGY, 2008, 381 (01) :106-115

← 1 2 3 4 5 6 7 8 9 10 →